Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Highly recommend Great experience with this product
This foundational dosing schedule allows healthcare providers to monitor patient response and adjust treatment as needed
avoid repeated freezethaw cycles Dosing Protocol A stepwise titration approach is used to improve tolerance and effectiveness: Weeks 18: 500 mcg daily Weeks 912: Increase to 1000 mcg daily Weeks 1316: Increase to 1500 mcg daily (if well tolerated) Frequency: Once daily (subcutaneous injection) Timing: Any consistent time of day Site Rotation: Alternate between abdomen and thighs Storage Instructions Proper handling helps maintain peptide stability and effectiveness: Lyophilized form: Store at 20C (4F) in a dry, dark environment After reconstitution: Refrigerate at 28C (35.646.4F) Usage window: Best used within ~30 days Avoid repeated freezethaw cycles Allow vial to reach room temperature before opening to reduce moisture buildup Important Notes Use a new sterile insulin syringe (2730G) for each injection Dispose of all sharps safely after use Rotate injection sites to minimize irritation or tissue buildup Inject slowly and wait briefly before removing the needle Common temporary effects may include nausea, flushing, or mild headache Keeping a simple log of dose and injection site can help maintain consistency How This Works Bremelanotide is a synthetic analog of -MSH that acts as a non-selective melanocortin receptor agonist , primarily targeting MC3R and MC4R
Researchers studying AOD-9604 dosing protocols and AOD-9604 combined with incretin agonists may find a safer combination pathway that addresses similar goals with less unknown risk
5-Amino-1MQ has high membrane permeability, meaning it absorbs well and reaches target tissues effectively
